Calcium and Vitamin D Supplementation Increase Weight Loss Effect on Lipids

In addition the 50% reduction in fracture risk quoted by the manufacturers of these drugs and some physicians, is at best misleading and at worst down right deceptive.

This drug (if one existed, it doesn’t) could legitimately state it reduced fracture risk by 50%

Well, they do a study approved by the FDA and show that when you take their drug, instead of 2 people out of 100 people experiencing a fracture, only 1 person out of 100 people experienced a fracture.

In addition to the multiple, potential side-effects of these drugs which will be listed shortly, these drugs do not create new healthy bone, instead they create bone that is unnatural and nothing like new bone formed by the body.

So people wind up with bone that is architecturally very different from new bone created by the body.

  • Esosphageal cancer
  • Upper GI irritation
  • Irregular heartbeat
  • Fractures of the femur
  • Low calcium in the blood
  • Skin rash
  • Joint, bone, and muscle pain
  • Jaw bone decay (osteonecrosis)
  • Increased parathyroid hormone (PTH)

 

Sensible, Effective and Much Safer Options to Reduce Your Fracture Risk

Cultures that consume far less than the 1500 mg of calcium per day recommended by many physicians, experience much lower fracture rates than we do. This is because their diets contain some specific ingredients that help calcium to enter their bones.

Two recent studies, one examining the fracture reducing potential of bisphosphonate drugs and the second measuring the fracture reducing potential of Vitamin D, demonstrated that Vitamin D is perhaps more effective than the drugs, with none of the inherent risks and side-effects of the drugs.

Interestingly, several studies have shown that both Vitamin K-1 and K-2 have decreased fracture risks in humans without increasing Bone Mineral Density (BMD).

Say “NO” to Osteoporosis Drugs and High Dose Calcium for Preventing Bone Fractures

A correlation was observed between calcium intake and high density lipoprotein (HDL) cholesterol at the beginning of the study.